Xeris Pharmaceuticals | XERS - EPS Earnings Per Share


Xeris Pharmaceuticals reported $0 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Celltrion KRW 1.13K 317.83 Sep/2025
Cspc Pharmaceutical CNY 0.08 0.01 Sep/2025
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Divis Laboratories Ltd INR 25.97 5.48 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.03 0.07 Jun/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 0 0 Jun/2025
Neuren Pharmaceuticals AUD 0.06 0.97 Jun/2025
Organigram Holdings CAD -0.18 0.13 Sep/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pharma Mar EUR -0.23 1.55 Sep/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Sartorius EUR 1.26 0.63 Dec/2025
Sino Biopharmaceutical CNY 0.16 0.07 Jun/2025
Supernus Pharmaceuticals USD -0.8 1.2 Sep/2025
Tilray USD -0.41 0.4 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025